Both in Pharmaceuticals
Verastem vs Corvus Pharmaceuticals
Over the past year VSTM returned −6.6% and CRVS returned +23.3%; their daily moves had a correlation of 0.16.
VSTM −6.6% CRVS +23.3%Growth of $1, one year, split-adjusted
| Metric | VSTM | CRVS |
|---|---|---|
| Price | $8.78 | $9.48 |
| Market cap | $794.7M | $797.5M |
| Today | −4.93% | −3.76% |
| 1 month | +16.2% | −24.5% |
| 6 months | +33.4% | −43.4% |
| Year to date | +13.7% | +23.1% |
| 1 year | −6.6% | +23.3% |
| Revenue growth (YoY) | +1775.4% | — |
| Gross margin | 89.9% | — |
| Net margin | −86.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 9.1× | — |
| Net cash | $54.6M | $215.2M |
| Dividend yield | — | — |
| Volatility (60d) | 71.3% | 50.2% |
| Short % of float | 17.7% | 25.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).